MOUNTAIN VIEW, Calif., March 6, 2025 /PRNewswire/ — Expanding Innovations™ (EI), an emerging leader in expandable implant technology for spine surgery, announced today that it will be attending and participating in the Canaccord Genuity Musculoskeletal and LSI USA Investor Conferences in March, 2025.
Connect with Expanding Innovations to learn more about:
About Expanding Innovations
Expanding Innovations™ is an emergiwng medical device leader in expandable implant technology for spine surgery. Committed to solving the most formidable clinical problems faced by today’s spine surgeons, EI recognized the need to develop a next-generation expandable interbody cage platform that would mitigate the incidence of post-op cage collapse and vertebral body subsidence. Rising to the challenge, EI developed a revolutionary, NON-SCREW-based expandable cage that surgeons and patients can count on. X-PAC® Expandable Interbody Cages replace the traditional inner implant drive screw with a powerful, continuous lifting mechanism. This patented lifting mechanism provides exceptional tactile feedback to the surgeon throughout implant expansion and robust locking of the implant upon completion of expansion. With over 14,000 cages implanted, surgeon adoption and trust in X-PAC Expandable Interbody Cage technology continues to grow across the United States. Expanding Innovations continues to innovate with significant technology advancements and planned expansion of its X-PAC Portfolio in 2026.
For more information about Expanding Innovations and our participation in these events, please visit ExpandingInnovations.com or follow us on LinkedIn.
SOURCE Expanding Innovations
Alcohol Detoxification and Anti-Hangover Beverage (Available on amazon.com and unbuzzd.com) to be distributed exclusively by…
Bringing affordable in-home and virtual primary care to Seattle, Tacoma, Everett, and SpokaneMINNEAPOLIS, April 02,…
VANCOUVER, British Columbia and LAS VEGAS, April 02, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc.…
ST. PETERSBURG, Fla., April 02, 2025 (GLOBE NEWSWIRE) -- 2025, a popular supplement for reviving…
IRVINE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a leading diagnostics…
HOUSTON, TX, April 02, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the…